Table of Contents 1 Non-small Cell Lung Cancer Drugs Market Overview 1.1 Product Overview and Scope of Non-small Cell Lung Cancer Drugs 1.2 Classification of Non-small Cell Lung Cancer Drugs by Types 1.2.1 Global Non-small Cell Lung Cancer Drugs Revenue Comparison by Types (2019-2024) 1.2.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Types in 2018 1.2.3 Biologics 1.2.4 Small Molecule Targeted Therapy 1.2.5 Chemotherapy 1.2.6 Other 1.3 Global Non-small Cell Lung Cancer Drugs Market by Application 1.3.1 Global Non-small Cell Lung Cancer Drugs Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Lung Adenocarcinoma 1.3.3 Squamous Cell Lung Carcinoma 1.3.4 Large-cell Lung Carcinoma 1.4 Global Non-small Cell Lung Cancer Drugs Market by Regions 1.4.1 Global Non-small Cell Lung Cancer Drugs Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024) 1.5 Global Market Size of Non-small Cell Lung Cancer Drugs (2014-2024) 2 Company Profiles 2.1 AstraZeneca 2.1.1 Business Overview 2.1.2 Non-small Cell Lung Cancer Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AstraZeneca Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.2 F. Hoffmann-La Roche Ltd 2.2.1 Business Overview 2.2.2 Non-small Cell Lung Cancer Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.3 Bristol-Myers Squibb Company 2.3.1 Business Overview 2.3.2 Non-small Cell Lung Cancer Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.4 Eli Lilly and Company 2.4.1 Business Overview 2.4.2 Non-small Cell Lung Cancer Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) 2.5 Merck & Co., Inc. 2.5.1 Business Overview 2.5.2 Non-small Cell Lung Cancer Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) 3 Global Non-small Cell Lung Cancer Drugs Market Competition, by Players 3.1 Global Non-small Cell Lung Cancer Drugs Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Non-small Cell Lung Cancer Drugs Players Market Share 3.2.2 Top 10 Non-small Cell Lung Cancer Drugs Players Market Share 3.3 Market Competition Trend 4 Global Non-small Cell Lung Cancer Drugs Market Size by Regions 4.1 Global Non-small Cell Lung Cancer Drugs Revenue and Market Share by Regions 4.2 North America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 4.3 Europe Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 4.5 South America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 5 North America Non-small Cell Lung Cancer Drugs Revenue by Countries 5.1 North America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019) 5.2 USA Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 5.3 Canada Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 5.4 Mexico Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 6 Europe Non-small Cell Lung Cancer Drugs Revenue by Countries 6.1 Europe Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019) 6.2 Germany Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 6.3 UK Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 6.4 France Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 6.5 Russia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 6.6 Italy Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue by Countries 7.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019) 7.2 China Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 7.3 Japan Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 7.4 Korea Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 7.5 India Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 8 South America Non-small Cell Lung Cancer Drugs Revenue by Countries 8.1 South America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019) 8.2 Brazil Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 8.3 Argentina Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 8.4 Colombia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Non-small Cell Lung Cancer Drugs by Countries 9.1 Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019) 9.2 Saudi Arabia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 9.3 UAE Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 9.4 Egypt Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 9.5 Nigeria Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 9.6 South Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) 10 Global Non-small Cell Lung Cancer Drugs Market Segment by Type 10.1 Global Non-small Cell Lung Cancer Drugs Revenue and Market Share by Type (2014-2019) 10.2 Global Non-small Cell Lung Cancer Drugs Market Forecast by Type (2019-2024) 10.3 Biologics Revenue Growth Rate (2014-2024) 10.4 Small Molecule Targeted Therapy Revenue Growth Rate (2014-2024) 10.5 Chemotherapy Revenue Growth Rate (2014-2024) 10.6 Other Revenue Growth Rate (2014-2024) 11 Global Non-small Cell Lung Cancer Drugs Market Segment by Application 11.1 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application (2014-2019) 11.2 Non-small Cell Lung Cancer Drugs Market Forecast by Application (2019-2024) 11.3 Lung Adenocarcinoma Revenue Growth (2014-2019) 11.4 Squamous Cell Lung Carcinoma Revenue Growth (2014-2019) 11.5 Large-cell Lung Carcinoma Revenue Growth (2014-2019) 12 Global Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2024) 12.1 Global Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2024) 12.2 Global Non-small Cell Lung Cancer Drugs Market Forecast by Regions (2019-2024) 12.3 North America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) 12.4 Europe Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) 12.6 South America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Non-small Cell Lung Cancer Drugs Picture Table Product Specifications of Non-small Cell Lung Cancer Drugs Table Global Non-small Cell Lung Cancer Drugs and Revenue (Million USD) Market Split by Product Type Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Types in 2018 Figure Biologics Picture Figure Small Molecule Targeted Therapy Picture Figure Chemotherapy Picture Figure Other Picture Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Application (2014-2024) Figure Non-small Cell Lung Cancer Drugs Revenue Market Share by Applications in 2018 Figure Lung Adenocarcinoma Picture Figure Squamous Cell Lung Carcinoma Picture Figure Large-cell Lung Carcinoma Picture Table Global Market Non-small Cell Lung Cancer Drugs Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Non-small Cell Lung Cancer Drugs Type and Applications Table AstraZeneca Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors Table F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Type and Applications Table F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Type and Applications Table Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table Eli Lilly and Company Non-small Cell Lung Cancer Drugs Type and Applications Table Eli Lilly and Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors Table Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Type and Applications Table Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018) Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Players (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Revenue Share by Players (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Players in 2017 Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Players in 2018 Figure Global Top 5 Players Non-small Cell Lung Cancer Drugs Revenue Market Share in 2018 Figure Global Top 10 Players Non-small Cell Lung Cancer Drugs Revenue Market Share in 2018 Figure Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Regions (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Regions (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Regions (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Regions in 2018 Figure North America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Europe Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure South America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Table North America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019) Table North America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure North America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure North America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018 Figure USA Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Canada Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Mexico Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Table Europe Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Countries (2014-2019) Figure Europe Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure Europe Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018 Figure Germany Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure UK Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure France Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Russia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Italy Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Table Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018 Figure China Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Japan Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Korea Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure India Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Southeast Asia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Table South America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019) Table South America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure South America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure South America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018 Figure Brazil Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Argentina Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Colombia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Table Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018 Figure Saudi Arabia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure UAE Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Egypt Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure Nigeria Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Figure South Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Type (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Revenue Share by Type (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Type (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Type in 2018 Table Global Non-small Cell Lung Cancer Drugs Revenue Forecast by Type (2019-2024) Figure Global Non-small Cell Lung Cancer Drugs Market Share Forecast by Type (2019-2024) Figure Global Biologics Revenue Growth Rate (2014-2019) Figure Global Small Molecule Targeted Therapy Revenue Growth Rate (2014-2019) Figure Global Chemotherapy Revenue Growth Rate (2014-2019) Figure Global Other Revenue Growth Rate (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Revenue by Application (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Application in 2018 Table Global Non-small Cell Lung Cancer Drugs Revenue Forecast by Application (2019-2024) Figure Global Non-small Cell Lung Cancer Drugs Market Share Forecast by Application (2019-2024) Figure Global Lung Adenocarcinoma Revenue Growth Rate (2014-2019) Figure Global Squamous Cell Lung Carcinoma Revenue Growth Rate (2014-2019) Figure Global Large-cell Lung Carcinoma Revenue Growth Rate (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share Forecast by Regions (2019-2024) Figure North America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) Figure Europe Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) Figure South America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024) Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)

AstraZeneca F. Hoffmann-La Roche Ltd Bristol-Myers Squibb Company Eli Lilly and Company Merck & Co., Inc.